Robert L. Gipson serves as Executive at ALSERES PHARMACEUTICALS INC /DE, where they oversee executive responsibilities. Since joining the company, Robert L. Gipson has executed 10 insider transactions totaling $2.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 27, 2011 involved selling 2,331,034 shares valued at $0.
Robert L. Gipson currently holds 15,376,004 shares of ALSERES PHARMACEUTICALS INC /DE (ALSE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert L. Gipson has been a net buyer of ALSE stock. They have purchased $2.0M and sold $0 worth of shares.
Robert L. Gipson's most recent insider trade was on Dec 27, 2011, when they sold 2,331,034 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 22, 2011 | ALSE | $5.8M | Option Exercise | 2,331,034 | $2.50 | Discretionary |
| Dec 16, 2011 | ALSE | $0 | Disposition | 60,000 | $N/A | Discretionary |
| Jun 1, 2011 | ALSE | $0 | Conversion | 4,600,000 | $N/A | Discretionary |
| Dec 31, 2010 | ALSE | $8.1K | Disposition | 270,000 | $0.03 | Discretionary |
| Jan 9, 2009 | ALSE | $1.0M | Purchase | 1,456,522 | $0.69 | Discretionary |
| Nov 20, 2008 | ALSE | $1000.0K | Purchase | 543,478 | $1.84 | Discretionary |
| Jun 11, 2007 | ALSE | $5.0M | Conversion | 2,000,000 | $2.50 | Discretionary |
| Jun 11, 2007 | ALSE | $5.0M | Conversion | 2,000,000 | $2.50 | Discretionary |